Cincinnati, Ohio -- A University of Cincinnati researcher thinks he is getting close to developing a canine hearing aid that could hit the market by the end of the year.
Cincinnati, Ohio
-- A University of Cincinnati researcher thinks he is getting close to developing a canine hearing aid that could hit the market by the end of the year.
Pete Scheifele started his research after his own 17-year-old dog lost his hearing. The highly trained miniature pinscher/beagle mix has appeared on television and performed for schools and didn't seem to mind wearing the prototype. In fact, he would seek it out and nudge it when he wasn't wearing it, according to Scheifele.
Researchers are now working on modifications to make the prototype version smaller and more comfortable. The hearing aid would only work on dogs with acquired hearing loss, says Scheifele, director of the University of Cincinnati's Facility for Education and Testing of Canine Hearing Laboratory for Animal Acoustics.
Scheifele says he is in discussions for commercialization of the prototype now and hopes is might be available for sale sometime later this year.
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More
Podcast CE: A Surgeon’s Perspective on Current Trends for the Management of Osteoarthritis, Part 1
May 17th 2024David L. Dycus, DVM, MS, CCRP, DACVS joins Adam Christman, DVM, MBA, to discuss a proactive approach to the diagnosis of osteoarthritis and the best tools for general practice.
Listen
dvm360 announces winners of the Veterinary Heroes program
Published: September 6th 2024 | Updated: November 5th 2024This year’s event is supported by corporate sponsor Schwarzman Animal Medical Center and category sponsors Blue Buffalo Natural, MedVet, Banfield Pet Hospital, Thrive Pet Healthcare and PRN Pharmacal.
Read More